Inovio Biomedical Corporation (INO) Universal Flu Vaccines Demonstrate Broadly Protective Immune Responses Against Multiple Seasonal & Pandemic Influenza Viruses in Pre-Clinical Studies
11/20/2009 8:33:13 AM
More...
|
Inovio Biomedical Corporation (INO) Universal DNA Vaccine for Chikungunya Virus Demonstrates Protective Antibody Responses in Monkey Model
11/19/2009 12:50:09 PM
More...
|
Inovio Biomedical Corporation (INO) Board of Directors Adds Two New Members
10/26/2009 10:06:04 AM
More...
|
DNA Vaccine Company Inovio Biomedical Corporation (INO) to Present at Rodman & Renshaw Investor Healthcare Conference
8/31/2009 8:53:56 AM
More...
|
Inovio Biomedical Corporation (INO), Fuelled By Swine Flu Fear, Comes Back From Brink With ‘Universal’ Vaccines
8/25/2009 7:56:57 AM
More...
|
Therapeutic DNA Vaccine Company Inovio Biomedical Corporation (INO) Reports Second Quarter 2009 Financial Results
8/20/2009 9:08:36 AM
More...
|
Inovio Biomedical Corporation (INO) to Present at Novel Vaccines: Design & Development
8/12/2009 8:53:06 AM
More...
|
Inovio Biomedical Corporation (INO): First Human Demonstration of Significant, Persistent Antibody Response Using Electroporation-Delivered DNA Vaccine Published in Human Gene Therapy
8/5/2009 9:51:21 AM
More...
|
Inovio Biomedical Corporation (INO) Closes $30 Million Registered Direct Offering
7/31/2009 11:21:07 AM
More...
|
Inovio Biomedical Corporation (INO), National Microbiology Laboratory, and University of Pennsylvania to Evaluate Candidate DNA Vaccines against "Swine" Influenza A (H1N1)
6/30/2009 9:18:50 AM
More...
|
|